We are live on ! Find out more
AIP

Ameritas Investment Partners Portfolio holdings

AUM $3.25B
1-Year Est. Return 28.52%
This Fund
S&P 500
This Quarter Est. Return
+13.11%
1 Year Est. Return
+28.52%
3 Year Est. Return
+86.82%
5 Year Est. Return
+110.6%
10 Year Est. Return
+500.3%
AUM
$2.02B
AUM Growth
+$31.2M
Cap. Flow
-$130M
Cap. Flow %
-6.43%
Top 10 Hldgs %
16.17%
Holding
2,969
New
1,707
Increased
193
Reduced
681
Closed
23

Sector Composition

Rank Sector Weight
1 Technology 13.08%
2 Financials 12.58%
3 Industrials 10.34%
4 Healthcare 9.4%
5 Consumer Discretionary 8.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MSBI icon
2676
Midland States Bancorp
MSBI
$692M
$10K ﹤0.01%
+287
New +$9.82K
NATR icon
2677
Nature's Sunshine
NATR
$282M
$10K ﹤0.01%
+1,018
New +$11.9K
NERV icon
2678
Minerva Neurosciences
NERV
$206M
$10K ﹤0.01%
+156
New +$12.1K
PROV icon
2679
Provident Financial
PROV
$113M
$10K ﹤0.01%
+514
New +$9.71K
RLGT icon
2680
Radiant Logistics
RLGT
$391M
$10K ﹤0.01%
+2,087
New +$9.61K
SPWH icon
2681
Sportsman's Warehouse
SPWH
$46.8M
$10K ﹤0.01%
+2,022
New +$12.6K
TPIC
2682
DELISTED
TPI Composites
TPIC
$10K ﹤0.01%
+506
New +$9.04K
TSQ icon
2683
Townsquare Media
TSQ
$100M
$10K ﹤0.01%
+783
New +$8.6K
TTGT icon
2684
TechTarget
TTGT
$273M
$10K ﹤0.01%
+1,109
New +$9.83K
XLE icon
2685
State Street Energy Select Sector SPDR ETF
XLE
$39.8B
$10K ﹤0.01%
312
DLA
2686
DELISTED
Delta Apparel Inc.
DLA
$10K ﹤0.01%
+555
New +$10.2K
RETA
2687
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$10K ﹤0.01%
+443
New +$10.9K
ISEE
2688
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$10K ﹤0.01%
+2,634
New +$11.1K
GBL
2689
DELISTED
GAMCO Investors, Inc.
GBL
$10K ﹤0.01%
+342
New +$10.3K
ATHX
2690
DELISTED
Athersys, Inc. Common Stock
ATHX
$10K ﹤0.01%
+237
New +$7.58K
CSLT
2691
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
$10K ﹤0.01%
+2,604
New +$9.14K
HOME
2692
DELISTED
At Home Group Inc.
HOME
$10K ﹤0.01%
+671
New +$10.1K
I
2693
DELISTED
INTELSAT S. A.
I
$10K ﹤0.01%
+2,452
New +$9.24K
WAAS
2694
DELISTED
AquaVenture Holdings Limited
WAAS
$10K ﹤0.01%
+599
New +$10.9K
SHLD
2695
DELISTED
Sears Holding Corporation
SHLD
$10K ﹤0.01%
+877
New +$7.33K
HDNG
2696
DELISTED
Hardinge Inc
HDNG
$10K ﹤0.01%
+911
New +$9.89K
BSF
2697
DELISTED
Bear State Financial, Inc.
BSF
$10K ﹤0.01%
+1,029
New +$10K
ISRL
2698
DELISTED
Isramco Inc
ISRL
$10K ﹤0.01%
+85
New +$10.4K
AP icon
2699
Ampco-Pittsburgh
AP
$199M
$9K ﹤0.01%
+667
New +$9.92K
ARWR icon
2700
Arrowhead Research
ARWR
$12.6B
$9K ﹤0.01%
+4,648
New +$9.22K

Similar funds

Ameritas Investment Partners's Q1 2017 Portfolio in Review

As of Q1 2017, Ameritas Investment Partners held 2,969 positions worth $2.02B, up 1.6% from $1.99B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Ameritas Investment Partners withdrew a net $130M in Q1 2017, closing 23 positions and reducing 681 holdings. Its most notable exit was Vanguard Total Bond Market, an estimated $34M position sold in full.

By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 12% a quarter earlier, followed by Financials and Industrials.

Against the trend, Ameritas Investment Partners opened a new position in Bioverativ Inc. Common Stock worth $2.4M.

  • Ameritas Investment Partners's largest Q1 2017 buy was Bioverativ Inc. Common Stock: 44,128 shares worth $2.4M.
  • Ameritas Investment Partners added most to State Street Health Care Select Sector SPDR ETF in Q1 2017, an estimated $2.78M increase.
  • Ameritas Investment Partners's biggest Q1 2017 reduction was iShares Core US Aggregate Bond ETF, cutting an estimated $61.8M.
  • Ameritas Investment Partners fully exited Vanguard Total Bond Market in Q1 2017, selling an estimated $34M.
  • Ameritas Investment Partners's ten largest holdings make up 16% of its $2.02B portfolio in Q1 2017.
  • Ameritas Investment Partners opened 1,707 new positions and closed 23 in Q1 2017.
  • Ameritas Investment Partners's portfolio value rose 1.6% quarter-over-quarter to $2.02B.

Based on Ameritas Investment Partners's 13F filing for Q1 2017, filed 9 May 2017.